Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Boehringer Ingelheim
McKinsey
Moodys
Johnson and Johnson

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Litigation Details for ASTRAZENECA AB v. LUPIN LTD. (D.N.J. 2009)

See Plans and Pricing

« Back to Dashboard

ASTRAZENECA AB v. LUPIN LTD. (D.N.J. 2009)

Docket   Start Trial Date Filed 2009-10-21
Court District Court, D. New Jersey Date Terminated 2012-01-26
Cause 35:271 Patent Infringement Assigned To Joel A. Pisano
Jury Demand None Referred To Magistrate Judge Tonianne J. B
Parties AKTIEBOLAGET HASSLE; ASTRAZENECA AB; ASTRAZENECA LP; KBI INC.; KBI-E INC.; LUPIN LTD.; LUPIN PHARMACEUTICALS, INC.
Patents 5,690,960; 5,900,424; 6,147,103; 6,166,213; 6,191,148; 6,428,810
Attorneys JONATHAN M.H. SHORT; KAREN A. CONFOY; WILLIAM J. HELLER
Link to Docket External link to docket
Small Molecule Drugs cited in ASTRAZENECA AB v. LUPIN LTD.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for ASTRAZENECA AB v. LUPIN LTD. (D.N.J. 2009)

Date Filed Document No. Description Snippet Link To Document
2009-12-11 12 U.S. PATENT NO. 5,690,960 147. Defendants repeat and incorporate…face of the patent is Astra Aktiebolag. Defendants further admit that a copy of the ‘504 patent was attached…that the patent was subsequently assigned to AstraZeneca AB. Defendants state that the ‘504 patent speaks…face of the patent is Astra Aktiebolag. Defendants further admit that a copy of the ‘192 patent was attached…that the patent was subsequently assigned to AstraZeneca AB. Defendants state that the ‘192 patent speaks External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Express Scripts
Boehringer Ingelheim
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.